Market revenue in 2023 | USD 5,471.2 million |
Market revenue in 2030 | USD 9,471.7 million |
Growth rate | 8.2% (CAGR from 2023 to 2030) |
Largest segment | Glucose testing |
Fastest growing segment | Glucose testing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Glucose testing, A1C testing, Direct LDL testing, Lipid panel testing, Prostate-specific antigen testing, COVID-19 testing, BUN testing, Vitamin D testing, Thyroid-stimulating hormone testing, Serum Nicotine / Cotinine testing, High sensitivity CRP testing, Testosterone testing, ALT testing, Cortisol testing, Creatinine testing, AST testing, Other blood tests |
Key market players worldwide | Abbott Laboratories, Roche Holding AG ADR, Bio-Rad Laboratories Inc, BioMerieux SA, Quest Diagnostics Inc, Biomerica Inc, Becton Dickinson & Co, Siemens Healthineers AG ADR, Danaher Corp, Trinity Biotech PLC ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood testing market will help companies and investors design strategic landscapes.
Glucose testing was the largest segment with a revenue share of 23.15% in 2023. Horizon Databook has segmented the Canada blood testing market based on glucose testing, a1c testing, direct ldl testing, lipid panel testing, prostate-specific antigen testing, covid-19 testing, bun testing, vitamin d testing, thyroid-stimulating hormone testing, serum nicotine / cotinine testing, high sensitivity crp testing, testosterone testing, alt testing, cortisol testing, creatinine testing, ast testing, other blood tests covering the revenue growth of each sub-segment from 2018 to 2030.
Canada is anticipated to witness lucrative growth in the near future owing to rise in the number of surgeries globally, which can be attributed to increase in the incidence of severe chronic diseases and accidents.
According to Canadian Medical Protective Association and Healthcare Insurance Reciprocal of Canada, every year, over one million surgeries are conducted in the country. Therefore, rise in the number of surgeries being performed in the country is expected to propel the market growth during the forecast period.
New market entrants that are strategically collaborating with companies based in the U.S. to increase their global presence are also expected to contribute to the market growth during the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada blood testing market , including forecasts for subscribers. This country databook contains high-level insights into Canada blood testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account